Records containing: Obesity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-12A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
-
CLINICAL_TRIALS study record update · 2026-03-12A Phase 3, Randomised, Double-blind, Parallel-group, 76-week, Efficacy and Safety Study of BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity Without Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2026-03-12A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic (PK) of Single-dose Administration of Semaglutide Nasal Spray (WL1006) in Adult Overweight or Obese Participants
-
CLINICAL_TRIALS study record update · 2026-03-12Efficacy and Safety of NNC0487-0111 s.c. Once-weekly Compared to Semaglutide s.c. Once-weekly in Participants With Overweight or Obesity, and Type 2 Diabetes (AMAZE 8)
-
CLINICAL_TRIALS study record update · 2026-03-11Workplace Health Promotion "So Healthy, Lose 99" Weight Loss Activity
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-11The Michigan Weight Navigation Program (MiWeigh) Study
-
CLINICAL_TRIALS study record update · 2026-03-11Unraveling the Role of Pro-Resolving Lipid Mediators of Inflammation and Their Receptors in Obesity-Associated Diseases: New Therapeutic Approaches for Maresin 1 (RESOLBE)
-
CLINICAL_TRIALS study record update · 2026-03-11Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder - OBOE-Mayo
-
CLINICAL_TRIALS study record update · 2026-03-11Predictors of Behavioral Obesity Treatment Outcomes
-
CLINICAL_TRIALS study record update · 2026-03-11Mindfulness and Acceptance Based Behavioral Treatment for Weight Loss
-
CLINICAL_TRIALS study record update · 2026-03-11The Impact of Weight Loss on Alzheimer's Disease Risk in Adults With Down Syndrome
-
CLINICAL_TRIALS study record update · 2026-03-11Effect and Safety of Semaglutide 7.2 mg Once-weekly in Participants With Obesity and Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2026-03-11A Phase 1/2, Randomized, Double-blind, Placebo-controlled, Study of the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of ALN-2232 as Monotherapy and Co-initiated With Tirzepatide in Adult Participants With Obesity
-
CLINICAL_TRIALS study record update · 2026-03-11Effect of Prebiotics in Saudi Adults With Type 2 Diabetes: Randomized Control Trail
-
CLINICAL_TRIALS study record update · 2026-03-10Effects of Executive Dysfunction on Physical Performance and General Well-Being in Obese Individuals
-
CLINICAL_TRIALS study record update · 2026-03-10Effect of Glucagon-like Peptide -1 Receptor Agonist on Liver Tissue and Plasma Lipids in MASLD
-
CLINICAL_TRIALS study record update · 2026-03-09Gut Microbiota, Diet-INDuced Obesity and Type 2 Diabetes in New Caledonia - MIND
-
CLINICAL_TRIALS study record update · 2026-03-09A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy
-
CLINICAL_TRIALS study record update · 2026-03-09Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue
-
CLINICAL_TRIALS study record update · 2026-03-09GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
-
CLINICAL_TRIALS study record update · 2026-03-06Evaluation of the Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction (CAMEO-SEMA) A Phase II, Prospective, Double-Blind Randomized Trial
-
CLINICAL_TRIALS study record update · 2026-03-06Safety Follow-up Study of Participants Previously Dosed With INV-347 in the First-in-Human Study INV-CL-108
-
CLINICAL_TRIALS study record update · 2026-03-05A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice
-
CLINICAL_TRIALS study record update · 2026-03-05A Cohort Study on Obese Patients' Multidisciplinary Integrated Health Management
-
CLINICAL_TRIALS study record update · 2026-03-05Investigating Factors Related to Nutritional Intake and Weight Gain Among Those With SCI Over the First 12 Months Following Discharge From Inpatient Rehabilitation